Shanghai Microport Medbot (Group) Co., Ltd. announced that it has entered into an agreement with investors to receive CNY 1,500,000,000 in an equity round of funding on August 31, 2020. The transaction will include participation from new investors Zhuhai Hillhouse Chongheng Equity Investment Enterprise (Limited Partnership), a fund managed by Zhuhai Hillhouse Equity Investment Management Co., Ltd. for CNY 771,430,000, Tianjin Ronghao Enterprise Management Partnership (LLP) for CNY 342,860,000, Jiaxing Biolink Hongrun Venture Capital LLP for CNY 171,430,000, Tianjin Yuanyi Yuanfu Enterprise Management Center for CNY 137,140,000, Yifang Huida Venture Capital (Guangdong) Partnership (Limited Partnership) for CNY 55,710,000, and Yifang Yida (Guangdong) Investment Partnership (Limited Partnership) for CNY 21,430,000. As a part of the transaction, Zhuhai Gaoling Chongheng Equity Investment Enterprise (Limited Partnership) and Tianjin Ronghao Enterprise Management Partnership (LLP) will appoint one member to the board of the company. The transaction is subject to all necessary approvals, including the approval of shareholders of the company. The transaction is expected to close within 15 business days of the satisfaction or waiver of all the conditions.